Posts: 1,995
Threads: 122
Joined: Feb 2018
Knight's gift was key to getting Dr Druker to return to his role as inaugural President of the Knight Cancer Center.
Druker was key to the development of Gleevec, which was featured on the cover of Time magazine in 2001. Gleevec was the first medication specifically designed to target cancer cells, leaving healthy cells mostly unharmed. This marked a significant shift in cancer treatment, moving towards a more precise and targeted approach. Chronic myeloid leukemia patients previously had an average life span of less than five years. With Gleevec and subsequent similar but even more effective treatments, average life span is now not far from normal.